ANG Lifesciences India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve the Unaudited Standalone ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India Ltd has informed BSE that its Board of Directors will meet on 14 February 2026 at 5:00 PM at its registered office in Amritsar. The main agenda is to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter and nine months ended 31 December 2025. The trading window for insiders is already closed from 1 January 2026 and will reopen 48 hours after the results are made public on 14 February 2026. No financial figures or outcomes are disclosed in this intimation — it is a routine advance notice as required under SEBI LODR Regulation 29.
This is a procedural filing with no direct impact on shareholders. Investors should watch for the actual Q3 results on 14 February 2026 for any meaningful updates on revenue, profitability, or margins.